TD Cowen initiated coverage on Intuitive Surgical with a new price target
$ISRG
Industrial Specialties
Health Care
TD Cowen initiated coverage of Intuitive Surgical with a rating of Buy and set a new price target of $660.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/11/2026 | $590.00 | Neutral → Buy | Citigroup |
| 1/27/2026 | $660.00 | Buy | TD Cowen |
| 12/11/2025 | $635.00 | Buy → Neutral | Citigroup |
| 7/23/2025 | Buy → Hold | Erste Group | |
| 6/9/2025 | $440.00 | Hold → Sell | Deutsche Bank |
| 6/5/2025 | Hold → Buy | Erste Group | |
| 12/2/2024 | $522.00 → $650.00 | Equal-Weight → Overweight | Morgan Stanley |
| 8/2/2024 | $380.00 → $510.00 | Neutral → Buy | Redburn Atlantic |
DEFA14A - INTUITIVE SURGICAL INC (0001035267) (Filer)
DEF 14A - INTUITIVE SURGICAL INC (0001035267) (Filer)
144 - INTUITIVE SURGICAL INC (0001035267) (Subject)
4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)
4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)
4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)
SAN CARLOS, Calif., March 24, 2026 /PRNewswire/ -- Sonder Capital, a healthcare venture capital firm investing in companies revolutionizing the standard of care, today announced the closing of its second fund, Futures II. The fund includes participation from Mayo Clinic and Sutter Health, reflecting their collective interest in innovative technologies that have the potential to advance the future of patient care by enhancing access, improving quality and transforming the overall patient experience."Through our second fund we'll continue enabling the next wave of companies and he
SUNNYVALE, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the completion of its acquisition of the da Vinci and Ion distribution business operated by ab medica, Abex, Excelencia Robótica, and their affiliates. The completion marks the formal expansion of Intuitive's direct operations in Europe, enabling the company to support customers in a more agile and integrated way, and bring minimally invasive care to more patients across Italy, Spain, Portugal, Malta, San Marino and associated territories. "Today marks an important step in our commitment to expand
SUNNYVALE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the da Vinci 5 system for certain cardiac procedures, including mitral valve repair and IMA (internal mammary artery) mobilization for cardiac revascularization. Cardiovascular disease remains the leading cause of death worldwide, claiming nearly 18 million lives each year.i More than two million patients worldwide undergo open heart surgery annuallyii, with most procedures requiring a sternotomy, an approach that involves splitting
Citigroup upgraded Intuitive Surgical from Neutral to Buy and set a new price target of $590.00
TD Cowen initiated coverage of Intuitive Surgical with a rating of Buy and set a new price target of $660.00
Citigroup downgraded Intuitive Surgical from Buy to Neutral and set a new price target of $635.00
Intel Corporation (NASDAQ:INTC) today announced that Craig H. Barratt, Ph.D., 63, has been appointed to its board of directors, effective immediately. Dr. Barratt will serve as an independent director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251110908011/en/Dr. Craig H. Barratt joins Intel's board as an independent director. "Craig is a highly accomplished technology leader with a proven ability to innovate, scale, and transform businesses," said Lip-Bu Tan, Intel CEO. "He is a seasoned semiconductor executive with experience at multiple leading-edge technology companies, which will be invaluable as we continue to execute
SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuit
President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t
SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025. Q4 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%.The Company placed 532 da Vinci surgical systems, compared with 493 in the fourth quarter of 2024. The fourth quarter 2025 da Vinci surgical system placements included 303 da Vinci 5 systems, compared with 174 i
SUNNYVALE, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2025 financial results ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. Financial and Operational Highlights Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew approximately 44%. Average da Vinci system utilization increased 4%
SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended September 30, 2025. Q3 Highlights Worldwide procedures (da Vinci and Ion combined) grew approximately 20% compared with the third quarter of 2024. Da Vinci procedures grew approximately 19% and Ion procedures grew approximately 52%.The Company placed 427 da Vinci surgical systems, compared with 379 in the third quarter of 2024. The third quarter 2025 da Vinci surgical system placements included 240 da Vinci 5 systems, compared with 110 in the
SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)
SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)
SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)